Related Experiment Video
Updated: Sep 3, 2025

13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
Target Enrichment Approaches for Next-Generation Sequencing Applications in Oncology
1Department of Molecular Oncology, Quest Diagnostics Nichols Institute, Chantilly, VA 20151, USA.
Diagnostics (Basel, Switzerland)
|July 27, 2022
Summary
Target enrichment is crucial for accurate and economical next-generation sequencing (NGS) in precision medicine. This review compares polymerase chain reaction-based and hybridization capture methods for genomic variant screening.
Area of Science:
- Genomics
- Molecular Biology
- Biotechnology
Background:
- Genomic sequence variant screening is essential for precision medicine.
- Next-generation sequencing (NGS) offers high-throughput analysis of various genetic alterations.
- Target enrichment is a critical step to focus NGS on specific genomic regions.
Purpose of the Study:
- To review the principles of target enrichment methods for NGS.
- To compare polymerase chain reaction-based and hybridization capture techniques.
- To discuss variations, automation, and commercial options for target enrichment.
Main Methods:
- Summarizes principles of PCR-based (amplicon) and hybridization capture-based target enrichment.
- Discusses variations, automation, and commercial availability of these methods.
Main Results:
- Both PCR-based and hybridization capture methods are prominent for target enrichment.
- Each method has distinct advantages and drawbacks influencing accuracy and cost-effectiveness.
Conclusions:
- Effective target enrichment is vital for efficient and precise genomic variant screening using NGS.
- The choice of method depends on specific research or clinical needs, balancing accuracy, cost, and throughput.
Keywords:
NGSampliconhybridization capturenext-generation sequencingpolymerase chain reactiontarget enrichmentMore Related Videos
Related Concept Videos
Next-generation Sequencing
92.4K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
92.4K
RNA-seq
10.3K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.3K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K

